Cyanotech Corporation (CYAN)
| Market Cap | 2.82M -1.4% |
| Revenue (ttm) | 25.27M +8.5% |
| Net Income | -1.78M |
| EPS | -0.25 |
| Shares Out | 7.25M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 900 |
| Average Volume | 4,703 |
| Open | 0.3305 |
| Previous Close | 0.3761 |
| Day's Range | 0.3305 - 0.3891 |
| 52-Week Range | 0.2100 - 0.5740 |
| Beta | -0.08 |
| RSI | 54.08 |
| Earnings Date | Jun 23, 2026 |
About Cyanotech
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It... [Read more]
Financial Performance
In fiscal year 2025, Cyanotech's revenue was $24.22 million, an increase of 4.96% compared to the previous year's $23.07 million. Losses were -$3.20 million, -39.19% less than in 2024.
Financial StatementsNews
Cyanotech Earnings Call Transcript: Q2 2026
Second quarter results showed a 19.3% year-over-year increase in net sales and a 9-point gross margin expansion, with operating income turning positive. Cash and working capital declined, while operational improvements and price increases supported profitability.
Cyanotech Reports Financial Results for the Second Quarter of Fiscal 2026
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results ...
Cyanotech Earnings Call Transcript: Q1 2026
Net sales declined 1.3% year-over-year, but gross profit rose 20% due to production efficiencies. Bulk spirulina and astaxanthin sales surged, offsetting a decline in packaged products, while net loss improved 23% from last year.
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2026
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q1FY26.
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4 & FYE 2025.
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY25 and First Nine Months of Fiscal 2025.
Spirulina Beverages Market and Consumer Behaviour Analysis, 2025-2030 - Prolgae Spirulina Supplies, Cyanotech Corporation, FUL Foods, Sol-Ti, and Raw Juicery Lead the Projected $61 Million Market
Online Retail for Spirulina Beverages Positioned to Witness the Highest CAGR During the Forecast Period Online Retail for Spirulina Beverages Positioned to Witness the Highest CAGR During the Forecast...
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q2FY25 and First Six Months of Fiscal 2025.
CYAN Stock Surges 6.58% on U.S. OTC Market Amid Sector Decline
CYAN (CYAN, Financial), a company listed on the U.S. OTC market, experienced a significant stock price increase of 6.58%. The stock is currently trading at $0.81 per share with a trading volume of 6,8...
Cyanotech Earnings Call Transcript: Q1 2025
Net sales increased 15% year-over-year to $5.9 million, driven by astaxanthin sales and new product launches. Gross margin declined due to higher costs, but net loss narrowed to $1.2 million. Working capital fell sharply, with liquidity and debt reclassification noted.
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2025
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q1FY25.
Cyanotech Earnings Call Transcript: Q4 2024
Sales remained flat for the year, with a shift toward packaged products and new gummy launches. Gross margins and net income declined due to higher costs and lower production, while preliminary financing was secured to support anticipated demand growth.
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4FY24 and Fiscal Year 2024.
Cyanotech Earnings Call Transcript: Q3 2024
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY24.
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024.
Cyanotech Earnings Call Transcript: Q1 2024
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024.
Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment.
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023.
Top 5 Defensive Stocks That Are Set To Fly
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Cyanotech Earnings Call Transcript: Q3 2023
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced fi...
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS
The New Board Members Will Bring Industry Experience to Contribute to Company Growth WOODINVILLE, Wash. , Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology c...